Trade Summary

1 week ago, Donovan Joanne M., serving as CMO at Edgewise Therapeutics, Inc. (EWTX), sold 16,358 shares at $30.98 per share, for a total transaction value of $506,735.00. Following this transaction, Donovan Joanne M. now holds 9,597 shares of EWTX.

This sale represents a 63.00% decrease in Donovan Joanne M.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 27, 2026 and publicly disclosed via SEC Form 4 filing on Monday, March 30, 2026, 3 days after the trade was made.

Edgewise Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.